| 【Company Research】Tsingtao Brewery (168 HK) – Results beat; premiumization accelerated in 4Q20 |
| 【Company Research】China Life - H (2628 HK) – NBV growth in line |
| 【Company Research】Simcere Pharmaceutical Group (2096 HK) – Increasing contribution from innovative products |
| 【Company Research】Meituan (3690 HK) – Reinvestment on new initiatives |
| 【Company Research】Antengene Corporation Limited (6996 HK) – Innovative and highly-differentiated pipelines focusing on oncology |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – Fast clinical progress for Proxalutamide and other core assets |
| 【Company Research】InnoCare Pharma (9969 HK) – Entering into commercial stage |
| 【Company Research】China East Education (667 HK) – YTD number of new students enrolled exceed pre-pandemic level |
| 【Company Research】Haidilao (6862 HK) – Gradual recovery and store expansion intact |
| 【Company Research】Q Technology (1478 HK) – Stronger CCM outlook in 2021; Raise TP to HK$23.0 |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
